Table 2.
Clinical features and outcome related gender in CM patients
| Male (n = 77) | Female (n = 31) | P | |
|---|---|---|---|
| Symptoms | |||
| Headache, no. (%) | 57 (74.0) | 24 (77.4) | 0.713 |
| Fever, no. (%) | 48 (62.3) | 19 (61.3) | 0.919 |
| Seizure, no. (%) | 5 (6.5) | 3 (9.7) | 0.687 |
| Dizziness, no. (%) | 1 (1.3) | 1 (3.2) | 0.494 |
| Ataxia, no. (%) | 3 (3.9) | 1 (3.2) | 1 |
| Unconsciousness, no. (%) | 11 (14.3) | 8 (25.8) | 0.155 |
| Psychosis, no. (%) | 2 (2.6) | 2 (6.5) | 0.577 |
| CSF, mean ± SD | |||
| Ratio of CSF glucose/Blood glucose, mean ± SD | 0.30 ± 0.18 | 0.28 ± 0.18 | 0.54 |
| CSF pressure (mmH2O), mean ± SD | 266.49 ± 60.13 | 271.94 ± 49.49 | 0.66 |
| CSF glucose (mmol/L), mean ± SD | 2.08 ± 1.36 | 1.64 ± 1.01 | 0.80 |
| CSF protein (g/L), mean ± SD | 0.94 ± 1.53 | 0.86 ± 0.51 | 0.11 |
| Abnormal EEGa, no. (%) | 17 (68.0) | 10 (76.9) | 0.71 |
| Abnormal MRIb, no. (%) | 25 (75.8) | 9 (60.0) | 0.31 |
| Outcome | |||
| Hospitalization length (days), mean ± SD | 50.71 ± 55.36 | 53.35 ± 53.93 | 0.44 |
| Survival time (months), mean ± SD | 30.40 ± 45.30 | 21.22 ± 36.15 | 0.09 |
| Dead, no. (%) | 30 (45.5) | 15 (53.6) | 0.47 |
aAbnormal EEG included 5 cases had normal background with focal slow wave and 5 had diffused slow wave in the background
bAbnormal MRI included Bubble sign 5 cases (2 at the basal ganglion and 3 at subcortex), hydrocephalus 5 cases and 6 cases with abnormal cerebral lesions (6 cases with more than one abnormal features)